Oseltamivir Phosphate for Oral Suspension
- Product NDC
- 72516-029
- 11-digit product format
- 725160029
- Labeler code
- 72516
- Product ID
- 72516-029_4627bcf0-5295-1d6d-e063-6394a90ab3ce
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oseltamivir Phosphate
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Oryza Pharmaceuticals Inc.
- Application
- ANDA217303
- Marketing category
- ANDA
- Marketing start
- 2025-10-19
- Substance
- OSELTAMIVIR PHOSPHATE
- Active strength
- 6 mg/mL
- Pharmacologic classes
- Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Oseltamivir Phosphate for Oral Suspension
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OSELTAMIVIR PHOSPHATE | 6 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4A3O49NGEZ |
| Rxcui | 1115698 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72516-029-01 | Oseltamivir Phosphate for Oral Suspension | 1 in 1 CARTON | POWDER, FOR SUSPENSION | 1 | | 2 |
| 72516-029-01 | Oseltamivir Phosphate for Oral Suspension | 60 mL in 1 BOTTLE, GLASS | POWDER, FOR SUSPENSION | 60 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 72516-029-01 | 72516002901 | 1 BOTTLE, GLASS in 1 CARTON (72516-029-01) / 60 mL in 1 BOTTLE, GLASS | 2025-10-19 | No | No | Current |